• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[伴有鞘内播散的小脑胶质母细胞瘤:4例报告]

[Cerebellar Glioblastoma with Intrathecal Dissemination:A Report of Four Cases].

作者信息

Ishikawa Mariko, Sumita Kazutaka, Tamura Kaoru, Kobayashi Daisuke, Tsukahara Yusuke, Inaji Motoki, Tanaka Yoji, Nariai Tadashi, Maehara Taketoshi

机构信息

Department of Neurosurgery, Tokyo Medical and Dental University.

出版信息

No Shinkei Geka. 2020 Mar;48(3):237-244. doi: 10.11477/mf.1436204169.

DOI:10.11477/mf.1436204169
PMID:32201393
Abstract

Primary cerebellar glioblastoma is a rare disease that accounts for 0.4-3.4% of glioblastoma multiforme(GBM)cases. The clinicopathological characteristics and prognosis of primary cerebellar GBM are not well understood due to its rarity and the lack of an established treatment strategy. To elucidate the prognostic factors and dissemination pattern, we retrospectively assessed four cases of cerebellar GBM that we treated between 2003 and 2013. All cases involved men, and the age range was 53 to 76 years(median 69.5 years);each patient underwent surgical removal and received adjuvant chemotherapy or radiotherapy. Every cerebellar GBM patient developed intrathecal dissemination at every stage of cerebellar GBM. Two patients had spinal metastases with tumor recurrence, and no patient had brain stem invasion. mutation and MGMT expression were both negative in three cases. The median overall survival of cerebellar GBM patients was 13.8 years, and the median progression-free survival was 5.5 years, which is similar to that reported in previous reports-and similar in terms of results-for supratentorial GBM treated at the same time at our institution. In conclusion, the prognosis of cerebellar GBM appears to be similar to that of supratentorial GBM;however, the pattern of tumor progression, such as intrathecal dissemination, is different. Craniospinal irradiation on cerebellar GBM should be carefully considered with frequent follow-up by whole spine survey using MRI.

摘要

原发性小脑胶质母细胞瘤是一种罕见疾病,占多形性胶质母细胞瘤(GBM)病例的0.4 - 3.4%。由于其罕见性以及缺乏既定的治疗策略,原发性小脑GBM的临床病理特征和预后尚不清楚。为了阐明预后因素和播散模式,我们回顾性评估了2003年至2013年间我们治疗的4例小脑GBM病例。所有病例均为男性,年龄范围为53至76岁(中位年龄69.5岁);每位患者均接受了手术切除,并接受了辅助化疗或放疗。每例小脑GBM患者在小脑GBM的各个阶段均发生了鞘内播散。2例患者出现脊髓转移并伴有肿瘤复发,无一例患者有脑干侵犯。3例患者的 突变和MGMT表达均为阴性。小脑GBM患者的中位总生存期为13.8年,中位无进展生存期为5.5年,这与先前报道的结果相似,并且与我们机构同期治疗的幕上GBM的结果相似。总之,小脑GBM的预后似乎与幕上GBM相似;然而,肿瘤进展模式,如鞘内播散,是不同的。对于小脑GBM应仔细考虑进行全脑全脊髓照射,并通过MRI进行全脊柱检查进行频繁随访。 (注:原文中“ mutation”这里有缺失信息)

相似文献

1
[Cerebellar Glioblastoma with Intrathecal Dissemination:A Report of Four Cases].[伴有鞘内播散的小脑胶质母细胞瘤:4例报告]
No Shinkei Geka. 2020 Mar;48(3):237-244. doi: 10.11477/mf.1436204169.
2
A retrospective study of primary cerebellar glioblastoma multiforme in adults.成人原发性小脑多形性胶质母细胞瘤的回顾性研究。
J Clin Neurosci. 2012 Dec;19(12):1684-8. doi: 10.1016/j.jocn.2011.12.035. Epub 2012 Oct 16.
3
Outcome and prognostic factors in adult cerebellar glioblastoma.成人小脑胶质母细胞瘤的预后和预后因素。
J Clin Neurosci. 2013 Aug;20(8):1117-21. doi: 10.1016/j.jocn.2012.12.006. Epub 2013 May 22.
4
Outcome and prognostic factors in cerebellar glioblastoma multiforme in adults: a retrospective study from the Rare Cancer Network.
Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):179-86. doi: 10.1016/j.ijrobp.2006.04.035. Epub 2006 Jul 11.
5
Glioblastoma with Primitive Neuroectodermal Component Treated with Adjuvant Radiotherapy and Temozolomide: A Pooled Analysis of 23 Patients.胶质母细胞瘤伴原始神经外胚层成分,采用辅助放疗和替莫唑胺治疗:23 例患者的汇总分析。
Neurol India. 2021 Jul-Aug;69(4):856-860. doi: 10.4103/0028-3886.323892.
6
Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results.胶质肉瘤与多形性胶质母细胞瘤的临床结局比较:北中部癌症治疗组的结果。
J Neurosurg. 1998 Sep;89(3):425-30. doi: 10.3171/jns.1998.89.3.0425.
7
Clinical outcome of gliosarcoma compared with glioblastoma multiforme: a clinical study in Chinese patients.胶质肉瘤与多形性胶质母细胞瘤的临床结局比较:一项针对中国患者的临床研究
J Neurooncol. 2016 Apr;127(2):355-62. doi: 10.1007/s11060-015-2046-0. Epub 2016 Jan 2.
8
Long-term survival in cerebellar glioblastoma multiforme. Case report.小脑多形性胶质母细胞瘤的长期生存。病例报告。
J Neurosurg Sci. 2012 Dec;56(4):379-81.
9
IDH mutation and MGMT promoter methylation are associated with the pseudoprogression and improved prognosis of glioblastoma multiforme patients who have undergone concurrent and adjuvant temozolomide-based chemoradiotherapy.异柠檬酸脱氢酶(IDH)突变和O6-甲基鸟嘌呤-DNA甲基转移酶(MGMT)启动子甲基化与接受同步和辅助替莫唑胺化疗放疗的多形性胶质母细胞瘤患者的假性进展及预后改善相关。
Clin Neurol Neurosurg. 2016 Dec;151:31-36. doi: 10.1016/j.clineuro.2016.10.004. Epub 2016 Oct 12.
10
Outcome and molecular characteristics of adolescent and young adult patients with newly diagnosed primary glioblastoma: a study of the Society of Austrian Neurooncology (SANO).新诊断原发性胶质母细胞瘤青少年和年轻成人患者的结局和分子特征:奥地利神经肿瘤学会(SANO)的一项研究。
Neuro Oncol. 2013 Jan;15(1):112-21. doi: 10.1093/neuonc/nos283. Epub 2012 Dec 7.

引用本文的文献

1
Circulating Tumor Cells for Glioma.用于胶质瘤的循环肿瘤细胞
Front Oncol. 2021 Mar 10;11:607150. doi: 10.3389/fonc.2021.607150. eCollection 2021.